Celiac Disease Market

Celiac Disease Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

210

Base Year:

2023

Nov - 2024

Format:

Report Code:

VMR-3190

Segments Covered

By Treatments Larazotide Acetate, Gluten Free Diet, Others
By Route of Administration Oral, Parenteral
By End-User Hospitals, Homecare, Others
By Distribution Channel Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 600.2 Million
Revenue 2032:	USD 1404.72 Million
Revenue CAGR (2024 - 2032):	9.9%
Fastest Growing Region (2024 - 2032)	Asia Pacific
Largest Region (2023):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Celiac Disease Market - Segment Analysis
1. Overview
2. Global Celiac Disease Market, 2016 - 2028 (USD Million)
3. Global Celiac Disease Market - by Treatments
  1. By Larazotide Acetate
  2. By Gluten Free Diet
  3. By Others
4. Global Celiac Disease Market - by Route of Administration
  1. By Oral
  2. By Parenteral
5. Global Celiac Disease Market - by End-User
  1. By Hospitals
  2. By Homecare
  3. By Others
6. Global Celiac Disease Market - by Distribution Channel
  1. By Hospital Pharmacy
  2. By Online Pharmacy
  3. By Retail Pharmacy
7. Global Celiac Disease Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
8. Market comparative analysis
North America Celiac Disease Market - Segment Analysis
1. Overview
2. North America Celiac Disease Market, 2016 - 2028 (USD Million)
3. North America Celiac Disease Market, by Treatments
  1. By Larazotide Acetate
  2. By Gluten Free Diet
  3. By Others
4. North America Celiac Disease Market, by Route of Administration
  1. By Oral
  2. By Parenteral
5. North America Celiac Disease Market, by End-User
  1. By Hospitals
  2. By Homecare
  3. By Others
6. North America Celiac Disease Market, by Distribution Channel
  1. By Hospital Pharmacy
  2. By Online Pharmacy
  3. By Retail Pharmacy
7. North America Celiac Disease Market, by Country
  1. U.S.
    1. U.S. Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. U.S. Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. U.S. Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. U.S. Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  2. Canada
    1. Canada Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Canada Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Canada Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Canada Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  3. Mexico
    1. Mexico Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Mexico Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Mexico Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Mexico Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
Europe Celiac Disease Market - Segment Analysis
1. Overview
2. Europe Celiac Disease Market, 2016 - 2028 (USD Million)
3. Europe Celiac Disease Market, by Treatments
  1. By Larazotide Acetate
  2. By Gluten Free Diet
  3. By Others
4. Europe Celiac Disease Market, by Route of Administration
  1. By Oral
  2. By Parenteral
5. Europe Celiac Disease Market, by End-User
  1. By Hospitals
  2. By Homecare
  3. By Others
6. Europe Celiac Disease Market, by Distribution Channel
  1. By Hospital Pharmacy
  2. By Online Pharmacy
  3. By Retail Pharmacy
7. Europe Celiac Disease Market, by Country
  1. Germany
    1. Germany Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Germany Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Germany Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Germany Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  2. UK
    1. UK Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. UK Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. UK Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. UK Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  3. France
    1. France Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. France Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. France Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. France Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  4. Spain
    1. Spain Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Spain Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Spain Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Spain Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  5. Italy
    1. Italy Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Italy Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Italy Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Italy Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  6. BENELUX
    1. BENELUX Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. BENELUX Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. BENELUX Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. BENELUX Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  7. Rest of Europe
    1. Rest Of Europe Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Rest Of Europe Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Rest Of Europe Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Rest Of Europe Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
Asia Pacific Celiac Disease Market - Segment Analysis
1. Overview
2. Asia Pacific Celiac Disease Market, 2016 - 2028 (USD Million)
3. Asia Pacific Celiac Disease Market, by Treatments
  1. By Larazotide Acetate
  2. By Gluten Free Diet
  3. By Others
4. Asia Pacific Celiac Disease Market, by Route of Administration
  1. By Oral
  2. By Parenteral
5. Asia Pacific Celiac Disease Market, by End-User
  1. By Hospitals
  2. By Homecare
  3. By Others
6. Asia Pacific Celiac Disease Market, by Distribution Channel
  1. By Hospital Pharmacy
  2. By Online Pharmacy
  3. By Retail Pharmacy
7. Asia Pacific Celiac Disease Market, by Country
  1. China
    1. China Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. China Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. China Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. China Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  2. Japan
    1. Japan Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Japan Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Japan Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Japan Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  3. India
    1. India Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. India Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. India Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. India Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  4. South Korea
    1. South Korea Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. South Korea Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. South Korea Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. South Korea Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  5. South East Asia
    1. South East Asia Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. South East Asia Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. South East Asia Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. South East Asia Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Rest of Asia Pacific Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Rest of Asia Pacific Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Rest of Asia Pacific Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
Latin America Celiac Disease Market - Segment Analysis
1. Overview
2. Latin America Celiac Disease Market, 2016 - 2028 (USD Million)
3. Latin America Celiac Disease Market, by Treatments
  1. By Larazotide Acetate
  2. By Gluten Free Diet
  3. By Others
4. Latin America Celiac Disease Market, by Route of Administration
  1. By Oral
  2. By Parenteral
5. Latin America Celiac Disease Market, by End-User
  1. By Hospitals
  2. By Homecare
  3. By Others
6. Latin America Celiac Disease Market, by Distribution Channel
  1. By Hospital Pharmacy
  2. By Online Pharmacy
  3. By Retail Pharmacy
7. Latin America Celiac Disease Market, by Country
  1. Brazil
    1. Brazil Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Brazil Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Brazil Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Brazil Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  2. Argentina
    1. Argentina Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Argentina Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Argentina Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Argentina Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  3. Rest of Latin America
    1. Rest of Latin America Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Rest of Latin America Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Rest of Latin America Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Rest of Latin America Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
Middle East & Africa Celiac Disease Market - Segment Analysis
1. Overview
2. Middle East & Africa Celiac Disease Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Celiac Disease Market, by Treatments
  1. By Larazotide Acetate
  2. By Gluten Free Diet
  3. By Others
4. Middle East & Africa Celiac Disease Market, by Route of Administration
  1. By Oral
  2. By Parenteral
5. Middle East & Africa Celiac Disease Market, by End-User
  1. By Hospitals
  2. By Homecare
  3. By Others
6. Middle East & Africa Celiac Disease Market, by Distribution Channel
  1. By Hospital Pharmacy
  2. By Online Pharmacy
  3. By Retail Pharmacy
7. Middle East & Africa Celiac Disease Market, by Country
  1. GCC Countries
    1. GCC Countries Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. GCC Countries Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. GCC Countries Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. GCC Countries Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  2. South Africa
    1. South Africa Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. South Africa Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. South Africa Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. South Africa Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Celiac Disease Market, By Treatments
      1. By Larazotide Acetate
      2. By Gluten Free Diet
      3. By Others
    2. Rest of Middle East & Africa Celiac Disease Market, By Route of Administration
      1. By Oral
      2. By Parenteral
    3. Rest of Middle East & Africa Celiac Disease Market, By End-User
      1. By Hospitals
      2. By Homecare
      3. By Others
    4. Rest of Middle East & Africa Celiac Disease Market, By Distribution Channel
      1. By Hospital Pharmacy
      2. By Online Pharmacy
      3. By Retail Pharmacy
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Asia Pacific Amgen
2. Anokion SA
3. BioLineRx Ltd
4. ChemoCentryx Inc. COUR Pharmaceutical
5. F. Hoffmann-La Roche Ltd
6. ImmunogenX
7. LLC
8. Innovate Biopharmaceuticals
9. Takeda Pharmaceutical Company Limited
10. and Teva Pharmaceutical Industries Ltd.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Celiac Disease in terms of revenue?

The global Celiac Disease valued at USD 600.2 Million in 2023 and is expected to reach USD 1404.72 Million in 2032 growing at a CAGR of 9.9%.

Which are the prominent players in the market?

The prominent players in the market are Asia Pacific Amgen, Anokion SA, BioLineRx Ltd, ChemoCentryx, Inc, COUR Pharmaceutical, F. Hoffmann-La Roche Ltd, ImmunogenX, LLC, Innovate Biopharmaceuticals, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 9.9% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Celiac Disease include

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Celiac Disease in 2023.

Celiac Disease Market

Celiac Disease Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Celiac Disease in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Celiac Disease Market

Celiac Disease Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Celiac Disease in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Celiac Disease Market

Vantage Point Interactive Dashboard